Ketotifen fumarate, 99%, Thermo Scientific Chemicals
Element SearchElement SearchStructure SearchStructure Search
Ketotifen fumarate, 99%, Thermo Scientific Chemicals
Ketotifen fumarate, 99%, Thermo Scientific Chemicals
Ketotifen fumarate, 99%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Ketotifen fumarate, 99%, Thermo Scientific Chemicals

CAS: 34580-14-8 | C23H23NO5S | 425.499 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
250 mg
Catalog number ALFJ63708.03
View Price:Sign in to see your account pricing. Need an account? Register with us today.
Quantity:
1 g
Request bulk or custom format
Chemical Identifiers
CAS2315-36-8
IUPAC Name2-chloro-N,N-diethylacetamide
Molecular FormulaC6H12ClNO
InChI KeyCQQUWTMMFMJEFE-UHFFFAOYSA-N
SMILESCCN(CC)C(=O)CCl
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)Clear colorless to yellow or pale pink
FormLiquid
Assay (GC)≥96.0%
Identification (FTIR)Conforms
Refractive Index1.4680-1.4730 @ 20?C
Ketotifen fumaratin is an H1 receptor antagonist. In its ophthalmic form, it is used to treat allergic conjunctivitis, or the itchy red eyes caused by allergies.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Soluble in water (10 mg/ml), DMSO (100 mM), and methanol.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.
RUO – Research Use Only

General References:

  1. MD Gregg J. Berdycorrespondence,; MD Dennis L. Spangler,; MD George Bensch,; MD Susan S. Berdy,; OD Robert C. Brusatti. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Clinical therapeutics. 2000, 22 (7), 826-833.
  2. Mayank Joshi,; Ambikanandan Misra.Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization. International Journal of Pharmaceutics. 2001, 223 (1-2).